Finally, the expression of CA IX in a number of breast tumours examined in this study, compared to the absence of CA IX in normal breast tissue, indicates that hypoxia and hypoxia-related gene expression may present a useful target for novel targeted therapies, for example drugs or gene therapy vectors that are specifically activated under hypoxic conditions. The gene discussed is CA9; the disease is breast neoplasm.